Cargando…
A Consideration of Fixed Dosing Versus Body Size‐Based Dosing Strategies for Chimeric Antigen Receptor T‐Cell Therapies
Autores principales: | He, Jimmy Zhijian, Wang, Hechuan, Lim, KyoungSoo, Ren, Song, Rollins, Fred, Vallaster, Markus, Wong, Ryan, Stebbings, Richard, Standifer, Nathan, Keefe, Robert, Phipps, Alex, Gibbs, Megan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826131/ https://www.ncbi.nlm.nih.gov/pubmed/36094760 http://dx.doi.org/10.1002/cpdd.1171 |
Ejemplares similares
-
Fixed Dose Versus Loose Dose: Analgesic Combinations
por: Pergolizzi, Joseph, et al.
Publicado: (2023) -
Entrectinib dose confirmation in pediatric oncology patients: pharmacokinetic considerations
por: Meneses-Lorente, Georgina, et al.
Publicado: (2023) -
Consideration of the usefulness of a size-specific dose estimate in pediatric CT examination
por: Tsujiguchi, Takakiyo, et al.
Publicado: (2018) -
The renaissance of fixed dose combinations: Combivir
por: Portsmouth, Simon D, et al.
Publicado: (2007) -
Fixed Dosing of Monoclonal Antibodies in Oncology
por: Hendrikx, Jeroen J.M.A., et al.
Publicado: (2017)